SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pacific Diagnostic Technologies (PDTK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dozer who wrote (51)1/16/1997 7:26:00 AM
From: chick in NC   of 262
 
Ryan:

IF (the big if) the Biotrack deal goes through, and IF (yipes! another one) proper marketing does indeed bring an additional $1 million each year in profits, my feeling we'll have a stock with a solid value of $3 by the end of 1998. I understand someone was hyping the stock on a small stock forum as reaching $6 again SOON -- very SOON. I'm just looking at PDTK's income potential at a PE of 20 (low for a biotech, I know) dividing by 10 million shares and rounding down. The stock has potential, but it needs 1. relief from downward pressure and 2. a clear marketing plan to attract both buyers and investors. The Biotrack is a great first step, but to prosper, the possible applications of the Stat-K technology need to be developed. Getting a waiver from the FDA on the training level required so the Stat-K could be operated in clinics rather than just hospitals in the U.S. would be another major plus.

Good luck with the studies and the stocks

Chick in NC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext